A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours. (2008)

First Author: Stronge RL
Attributed to:  The Centre of Excellence for Public Health (Northern Ireland) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1258/acb.2008.008033

PubMed Identifier: 18782815

Publication URI: http://europepmc.org/abstract/MED/18782815

Type: Journal Article/Review

Volume: 45

Parent Publication: Annals of clinical biochemistry

Issue: Pt 6

ISSN: 0004-5632